Sunday Aug 17
Omeros Corporation Estimates May Vary
Though virtually everything has gone well at Omeros Corporation since February 2013, the biopharmaceutical firm's stock remains speculative.
Sat Aug 16, 2014
Comparative efficacy and tolerability of 15 antipsychotic drugs in...
The question of which antipsychotic drug should be preferred for the treatment of schizophrenia is controversial, and conventional pairwise meta-analyses cannot provide a hierarchy based on the randomised evidence.
Neurocognition and its influencing factors in the treatment of...
To examine influencing variables of neurocognition in patients with schizophrenia and to predict cognition during antipsychotic treatment.
Quetiapine versus other atypical antipsychotics for schizophrenia.
In many countries, second-generation antipsychotic drugs have become the first-line drug treatment for people with schizophrenia.
The management of schizophrenia: focus on extended-release quetiapine fumarate.
Effective management of schizophrenia remains a significant clinical challenge. While antipsychotic medications have proven efficacy in this disease, there remains an opportunity to further improve symptom control and long-term relapse prevention.
Dimmer Switch For New Class Of Schizophrenia...
Schizophrenia affects about one percent of the world's population and, if untreated, leaves sufferers struggling with their relationships, jobs, and lives as a whole.
Thu Aug 14, 2014
The patient complained of insects crawling on her skin. Then she handed me a glass jar
Erica was hugely frustrated. "I've had the council round several times, they've fumigated the whole place twice, and still I'm getting bitten."
a systemically-available kynurenine aminotransferase II (Kat II)...
Kynurenic acid is a tryptophan metabolite that acts in the brain as an endogenous antagonist at multiple receptors, including glutamate and I 7 nicotinic acetylcholine receptors.
Wed Aug 13, 2014
Use of quetiapine XR and quetiapine IR in clinical practice for...
Quetiapine fumarate, a first-line treatment for schizophrenia, exists in two formulations: extended release and immediate release .
Tue Aug 12, 2014
Intra-Cellular Therapies, Inc. - 10-Q - Management's Discussion and...
You should read the following in conjunction with our unaudited condensed consolidated financial statements and the related notes thereto that appear elsewhere in this Quarterly Report on Form 10-Q and the audited consolidated financial statements and notes thereto and under the heading "Management's Discussion and Analysis of Financial Condition ... (more)
Aim for Next-Gen Schizophrenia Drugs Is Dimming Symptoms Without Side Effects
The approach is heralded as a method to manage the symptoms of schizophrenia without some of the side effects associated with current anti-psychotic medicines.
Mon Aug 11, 2014
Review: Fringe theatre
At least. The space itself is divided in two, with a separate drama running simultaneously on either side.
The Diagnosis of Schizophrenia in One's Child or Adolescent
Prior to the assessment of schizophrenia in children and adolescents, there are important considerations to be addressed by the parents of youths exhibiting behavior problems .
'Dimmer switch' drug idea could tackle schizophrenia
Affecting one per cent of the world's population, schizophrenia is a major health condition.
Wed Aug 06, 2014
This is Local London
VIDEOS: World's first anti-psychotic patch being tested by mental health trust
A new anti-psychotic patch for people with mental health disorders is being trialled by Surrey and Borders Partnership Trust The world's first anti-psychotic patch for people with disorders such as schizophrenia is being trialled by a mental health trust.
Sat Aug 02, 2014
Predictive validity of a MK-801-induced cognitive impairment model in ...
Predictive validity of a MK-801-induced cognitive impairment model in mice: implications on the potential limitations and challenges of modeling cognitive impairment associated with schizophrenia preclinically.
Fri Aug 01, 2014
A 4m project starts on schizophrenia drug
The team at the University of Sussex are hoping to have a compound ready for clinical testing in just over three years.
Wed Jul 30, 2014
New research shows lack of motivation affects cognitive performance in schizophrenia
New research from the Centre for Addiction and Mental Health shows a significant relationship between motivational deficit and poor cognitive performance in people with schizophrenia.
Cause is not everything in mental illness
Welcome steps have been made in uncovering a biological basis for schizophrenia, but for many, the question of 'why' is unimportant, says The past week has been big for mental illness.
InnoPharma Announces Launch of Olanzapine for Injection, 10mg/vial in Canada
Olanzapine is indicated for the rapid control of agitation and disturbed behaviors in patients with schizophrenia or bipolar I mania.